Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026
Go back to Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 233.45 -2.72 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.17 | 52 Week High | $160.00 | |||
| Open | $235.44 | 52 Week Low | $95.80 | |||
| Day High | $236.44 | P/E | 43.39 | |||
| Day Low | $230.56 | EPS | $5.38 | |||
| Volume | 352,097 | |||||
